217 related articles for article (PubMed ID: 22122125)
41. Albuminuria, serum antioxidant enzyme levels and markers of hemolysis and inflammation in steady state children with sickle cell anemia.
Itokua KE; Makulo JR; Lepira FB; Aloni MN; Ekulu PM; Sumaili EK; Bukabau JB; Mokoli VM; Longo AL; Kajingulu FM; Zinga CV; Nlandu YM; Engole YM; Akilimali PZ; Ngiyulu RM; Gini JL; Nseka NM
BMC Nephrol; 2016 Nov; 17(1):178. PubMed ID: 27855647
[TBL] [Abstract][Full Text] [Related]
42. Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes.
Embury SH; Clark MR; Monroy G; Mohandas N
J Clin Invest; 1984 Jan; 73(1):116-23. PubMed ID: 6690472
[TBL] [Abstract][Full Text] [Related]
43. Sickle cell disease--pathophysiology, clinical and diagnostic implications.
Dorn-Beineke A; Frietsch T
Clin Chem Lab Med; 2002 Nov; 40(11):1075-84. PubMed ID: 12521222
[TBL] [Abstract][Full Text] [Related]
44. Does physical activity increase or decrease the risk of sickle cell disease complications?
Martin C; Pialoux V; Faes C; Charrin E; Skinner S; Connes P
Br J Sports Med; 2018 Feb; 52(4):214-218. PubMed ID: 26701924
[TBL] [Abstract][Full Text] [Related]
45. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa.
Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B
Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524
[TBL] [Abstract][Full Text] [Related]
46. Vasculopathy and pulmonary hypertension in sickle cell disease.
Potoka KP; Gladwin MT
Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L314-24. PubMed ID: 25398989
[TBL] [Abstract][Full Text] [Related]
47. Low micromolar intravascular cell-free hemoglobin concentration affects vascular NO bioavailability in sickle cell disease: a computational analysis.
Deonikar P; Kavdia M
J Appl Physiol (1985); 2012 Apr; 112(8):1383-92. PubMed ID: 22223452
[TBL] [Abstract][Full Text] [Related]
48. Clinical biomarkers in sickle cell disease.
Damanhouri GA; Jarullah J; Marouf S; Hindawi SI; Mushtaq G; Kamal MA
Saudi J Biol Sci; 2015 Jan; 22(1):24-31. PubMed ID: 25561879
[TBL] [Abstract][Full Text] [Related]
49. Endothelial function in patients with sickle cell anemia during and after sickle cell crises.
Blum A; Yeganeh S; Peleg A; Vigder F; Kryuger K; Khatib A; Khazim K; Dauerman H
J Thromb Thrombolysis; 2005 Apr; 19(2):83-6. PubMed ID: 16052296
[TBL] [Abstract][Full Text] [Related]
50. [Not Available].
Bartolucci P
Rev Med Interne; 2023 Nov; 44(4S1):4S7-4S11. PubMed ID: 38049244
[TBL] [Abstract][Full Text] [Related]
51. Binding of ovarian steroids to erythrocytes in patients with sickle cell disease; effects on cell sickling and osmotic fragility.
Yoong WC; Tuck SM; Michael AE
J Steroid Biochem Mol Biol; 2003 Jan; 84(1):71-8. PubMed ID: 12648526
[TBL] [Abstract][Full Text] [Related]
52. Increased adhesive and inflammatory properties in blood outgrowth endothelial cells from sickle cell anemia patients.
Sakamoto TM; Lanaro C; Ozelo MC; Garrido VT; Olalla-Saad ST; Conran N; Costa FF
Microvasc Res; 2013 Nov; 90():173-9. PubMed ID: 24144783
[TBL] [Abstract][Full Text] [Related]
53. Clinical Biomarkers of Acute Vaso-Occlusive Sickle Cell Crisis.
Khurana K; Mahajan S; Acharya S; Kumar S; Toshniwal S
Cureus; 2024 Mar; 16(3):e56389. PubMed ID: 38633967
[TBL] [Abstract][Full Text] [Related]
54. The role of blood rheology in sickle cell disease.
Connes P; Alexy T; Detterich J; Romana M; Hardy-Dessources MD; Ballas SK
Blood Rev; 2016 Mar; 30(2):111-8. PubMed ID: 26341565
[TBL] [Abstract][Full Text] [Related]
55. Osmotic fragility of normal and sickle haemoglobin containing red blood cells.
Dash BP; Mittra A; Kar BC
Indian J Physiol Pharmacol; 1999 Apr; 43(2):267-9. PubMed ID: 10365325
[No Abstract] [Full Text] [Related]
56. Soluble Fas/FasL ratio as a marker of vasculopathy in children and adolescents with sickle cell disease.
Adly AA; Ismail EA; Andrawes NG; Mahmoud MM; Eladawy R
Cytokine; 2016 Mar; 79():52-8. PubMed ID: 26765484
[TBL] [Abstract][Full Text] [Related]
57. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
Hebbel RP; Osarogiagbon R; Kaul D
Microcirculation; 2004 Mar; 11(2):129-51. PubMed ID: 15280088
[TBL] [Abstract][Full Text] [Related]
58. Severity of Brazilian sickle cell disease patients: severity scores and feasibility of the Bayesian network model use.
Belini Junior E; Silva DG; Torres Lde S; Okumura JV; Lobo CL; Bonini-Domingos CR
Blood Cells Mol Dis; 2015 Apr; 54(4):321-7. PubMed ID: 25842370
[TBL] [Abstract][Full Text] [Related]
59. Sickle red cell microrheology and sickle blood rheology.
Ballas SK; Mohandas N
Microcirculation; 2004 Mar; 11(2):209-25. PubMed ID: 15280093
[TBL] [Abstract][Full Text] [Related]
60. The perfusion paradox and vascular instability in sickle cell disease.
Nath KA; Katusic ZS; Gladwin MT
Microcirculation; 2004 Mar; 11(2):179-93. PubMed ID: 15280091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
